Aandelen in “Productie van chirurgische apparatuur”

Aandeel	Datum	Koers	Evolutie
CollPlant Biotechnologies Ltd	30/04	2,120 USD -4,29%	-4,29%

Nieuws over “Productie van chirurgische apparatuur”

Toon enkel gratis nieuws

15/04 · CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies · Persbericht

15/04 · CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies · Persbericht

26/03 · COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE · Persbericht

19/03 · COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION · Persbericht

11/03 · Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025 · Persbericht

10/03 · Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025 · Persbericht

6/03 · New report confirms Smith+Nephew’s OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty · Persbericht

4/03 · Smith+Nephew is pioneering Spatial Surgery – a defining new Sports Medicine category pushing the boundaries of technology and procedural innovation · Persbericht

3/02 · Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe